Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales
Pacific Biosciences of California (NASDAQ: PACB) didn't fare so well the last time it provided a quarterly update. After the genetic-sequencing company reported its first-quarter results in late April, its bigger-than-expected net loss rattled investors.
The company announced its second-quarter results after the market closed on Wednesday, and the news wasn't any better than earlier this year. Here are the highlights.
Image source: Getty Images.
Source: Fool.com
Illumina Inc. Stock
€118.92
-1.460%
With 33 Buy predictions and 4 Sell predictions Illumina Inc. is one of the favorites of our community.
With a target price of 161 € there is a positive potential of 35.39% for Illumina Inc. compared to the current price of 118.92 €.
